Healthcare Market Research Reports & Industry Analysis

Publications found: 73,128

Sort by:

Deafness Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major deafness markets are expected to exhibit a CAGR of 3.3% during 2024-2034. The deafness market has been comprehensively analyzed in IMARC's new report titled 'Deafness Market: Epidemiology,...

May 2024 140 pages

Deep Vein Thrombosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major deep vein thrombosis markets reached a value of US$ 458.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 905.9 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 128 pages

Deglutition Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major deglutition disorders markets are expected to exhibit a CAGR of 4.1% during 2024-2034. The deglutition disorders market has been comprehensively analyzed in IMARC's new report titled 'Degl...

May 2024 138 pages

Delirium Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major delirium markets reached a value of US$ 187.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 283.0 Million by 2034, exhibiting a growth rate (CAGR) of 3.83% dur...

May 2024 140 pages

Dementia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dementia markets reached a value of US$ 6.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 12.8 Billion by 2034, exhibiting a growth rate (CAGR) of 5.85% during...

May 2024 128 pages

Dengue Fever Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dengue fever markets are expected to exhibit a CAGR of 10.21% during 2024-2034. The dengue fever market has been comprehensively analyzed in IMARC's new report titled 'Dengue Fever Market:...

May 2024 135 pages

Dermatomycosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dermatomycosis markets are expected to exhibit a CAGR of 3.47% during 2024-2034. The dermatomycosis market has been comprehensively analyzed in IMARC's new report titled 'Dermatomycosis Ma...

May 2024 128 pages

Dermatomyositis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dermatomyositis markets reached a value of US$ 192.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 278.0 Million by 2034, exhibiting a growth rate (CAGR) of 3....

May 2024 128 pages

Desmoid Tumors Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major desmoid tumors markets reached a value of US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.2 Billion by 2034, exhibiting a growth rate (CAGR) of 5.61% d...

May 2024 140 pages

Diabetic Foot Ulcers Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major diabetic foot ulcers markets reached a value of US$ 3.5 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5.4 Billion by 2034, exhibiting a growth rate (CAGR) of 3...

May 2024 134 pages

Diabetic Ketoacidosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major diabetic ketoacidosis markets are expected to exhibit a CAGR of 4.38% during 2024-2034. The diabetic ketoacidosis market has been comprehensively analyzed in IMARC's new report titled 'Dia...

May 2024 133 pages

Diabetic Macular Edema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major diabetic macular edema market reached a value of US$ 5.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.5 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 138 pages

Diabetic Nephropathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major diabetic nephropathy markets reached a value of US$ 9,717.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 14,572.9 Million by 2034, exhibiting a growth rate (C...

May 2024 134 pages

Diabetic Neuropathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034

US$ 6,499.00

The 7 major diabetic neuropathy markets reached a value of US$ 2.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.9 Billion by 2034, exhibiting a growth rate (CAGR) of 5....

May 2024 131 pages

Diabetic Peripheral Neuropathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major diabetic peripheral neuropathy markets reached a value of US$ 2,903.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5,365.9 Million by 2034, exhibiting a growt...

May 2024 134 pages

Diffuse Intrinsic Pontine Glioma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major diffuse intrinsic pontine glioma markets reached a value of US$ 3.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5.4 Billion by 2034, exhibiting a growth rate...

May 2024 130 pages

DiGeorge Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major diGeorge syndrome markets are expected to exhibit a CAGR of 4.78% during 2024-2034. The DiGeorge Syndrome market has been comprehensively analyzed in IMARC's new report titled 'DiGeorge Sy...

May 2024 134 pages

Diphtheria Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major diphtheria markets are expected to exhibit a CAGR of 4.31% during 2024-2034. The diphtheria market has been comprehensively analyzed in IMARC's new report titled 'Diphtheria Market: Epidem...

May 2024 138 pages

Donohue Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Donohue syndrome markets reached a value of US$ 11.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 22.6 Billion by 2034, exhibiting a growth rate (CAGR) of 6.0...

May 2024 129 pages

Doose Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major doose syndrome markets reached a value of US$ 687.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3,160.7 Million by 2034, exhibiting a growth rate (CAGR) of 1...

May 2024 136 pages

Down Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034?

US$ 6,499.00

The 7 major down syndrome markets reached a value of US$ 1.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.8 Billion by 2034, exhibiting a growth rate (CAGR) of 10.91% d...

May 2024 137 pages

Dravet Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Dravet syndrome markets reached a value of US$ 375.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 796.3 Million by 2034, exhibiting a growth rate (CAGR) of 7....

May 2024 135 pages

Drug-Resistant Epilepsy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major drug-resistant epilepsy markets reached a value of US$ 3.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 6.0 Billion by 2034, exhibiting a growth rate (CAGR) o...

May 2024 137 pages

Dry Age Macular Degeneration Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dry age macular degeneration markets are expected to exhibit a CAGR of 4.64% during 2024-2034. The dry age macular degeneration market has been comprehensively analyzed in IMARC's new repo...

May 2024 136 pages

Dupuytren's Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Dupuytren's disease markets are expected to exhibit a CAGR of 3.76% during 2024-2034. The Dupuytren's disease market has been comprehensively analyzed in IMARC's new report titled 'Dupuytr...

May 2024 136 pages

Dysautonomia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dysautonomia markets reached a value of US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5.5 Billion by 2034, exhibiting a growth rate (CAGR) of 9.22% dur...

May 2024 131 pages

Dyskinesia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dyskinesia markets are expected to exhibit a CAGR of 3.14% during 2024-2034. The dyskinesia market has been comprehensively analyzed in IMARC's new report titled 'Dyskinesia Market: Epidem...

May 2024 130 pages

Dyslipidemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dyslipidemia markets reached a value of US$ 5.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 8.8 Billion by 2034, exhibiting a growth rate (CAGR) of 3.84% dur...

May 2024 133 pages

Dysmenorrhea Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dysmenorrhea markets reached a value of US$ 10.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 18.5 Billion by 2034, exhibiting a growth rate (CAGR) of 5.44% d...

May 2024 128 pages

Dyspepsia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dyspepsia markets are expected to exhibit a CAGR of 3.49% during 2024-2034. The dyspepsia market has been comprehensively analyzed in IMARC's new report titled 'Dyspepsia Market: Epidemiol...

May 2024 128 pages

Dyspnea Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dyspnea markets are expected to exhibit a CAGR of 5.24% during 2024-2034. The dyspnea market has been comprehensively analyzed in IMARC's new report titled 'Dyspnea Market: Epidemiology, I...

May 2024 132 pages

Dyssomnias Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dyssomnias markets reached a value of US$ 16.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 19.3 Billion by 2034, exhibiting a growth rate (CAGR) of 1.68% dur...

May 2024 139 pages

Dysthymia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dysthymia markets are expected to exhibit a CAGR of 3.7% during 2024-2034. The dysthymia market has been comprehensively analyzed in IMARC's new report titled 'Dysthymia Market: Epidemiolo...

May 2024 130 pages

Dystrophic Epidermolysis Bullosa Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034

US$ 6,499.00

The 7 major dystrophic epidermolysis bullosa markets reached a value of US$ 525.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,857.8 Million by 2034, exhibiting a growt...

May 2024 132 pages

Eczema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major eczema markets reached a value of US$ 16.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 37.1 Billion by 2034, exhibiting a growth rate (CAGR) of 7.46% during...

May 2024 136 pages

Edward’s Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Edward’s syndrome markets reached a value of US$ 3.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.6 Billion by 2034, exhibiting a growth rate (CAGR) of 7.51...

May 2024 128 pages

EGFR Inhibitors-Induced Skin Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major EGFR inhibitors-induced skin disorders markets are expected to exhibit a CAGR of 17.89% during 2024-2034. The EGFR inhibitors-induced skin disorders market has been comprehensively analyze...

May 2024 135 pages

Ehlers-Danlos Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Ehlers-Danlos syndrome markets are expected to exhibit a CAGR of 3.42% during 2024-2034. The Ehlers-Danlos syndrome market has been comprehensively analyzed in IMARC's new report titled 'E...

May 2024 138 pages

Emesis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major emesis markets are expected to exhibit a CAGR of 4.18% during 2024-2034. The emesis market has been comprehensively analyzed in IMARC's new report titled 'Emesis Market: Epidemiology, Indu...

May 2024 140 pages

Emphysema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major emphysema markets reached a value of US$ 3.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.9 Billion by 2034, exhibiting a growth rate (CAGR) of 3.84% during...

May 2024 137 pages

Encephalitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major encephalitis markets reached a value of US$ 15.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 23.4 Billion by 2034, exhibiting a growth rate (CAGR) of 4.1% du...

May 2024 137 pages

End-Stage Renal Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major end-stage renal disease markets reached a value of US$ 76.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 218.2 Billion by 2034, exhibiting a growth rate (CAGR...

May 2024 137 pages

Endocarditis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major endocarditis markets are expected to exhibit a CAGR of 4.22% during 2024-2034. The endocarditis market has been comprehensively analyzed in IMARC's new report titled 'Endocarditis Market:...

May 2024 131 pages

Endometrial Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major endometrial cancer markets reached a value of US$ 20.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 29.5 Billion by 2034, exhibiting a growth rate (CAGR) of 3...

May 2024 133 pages

Eosinophilia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major eosinophilia markets reached a value of US$ 289.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 474.5 Million by 2034, exhibiting a growth rate (CAGR) of 4.61%...

May 2024 131 pages

Eosinophilic Esophagitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major eosinophilic esophagitis markets reached a value of US$ 896.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7,604.7 Million by 2034, exhibiting a growth rate (...

May 2024 137 pages

Ependymoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major ependymoma markets are expected to exhibit a CAGR of 4.03% during 2024-2034. The ependymoma market has been comprehensively analyzed in IMARC's new report titled 'Ependymoma Market: Epidem...

May 2024 131 pages

Epidermolysis Bullosa Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major epidermolysis bullosa markets reached a value of US$ 2,596.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3,929.8 Million by 2034, exhibiting a growth rate (C...

May 2024 131 pages

Epithelial Ovarian Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major epithelial ovarian cancer markets reached a value of US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 14.3 Billion by 2034, exhibiting a growth rate (CAGR...

May 2024 134 pages

Erdheim-Chester Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Erdheim-Chester disease markets are expected to exhibit a CAGR of 7.13% during 2024-2034. The Erdheim-Chester disease market has been comprehensively analyzed in IMARC's new report titled...

May 2024 135 pages

Filters

Clear all

Price

—

Date

—

Pages

—

Offers

33% OFF on “TCR-Based Antibody a...

Discount Offer from GMD Research

280

Special Offer from MP Advisors

Special Offer on Therapy Class R...